Intracerebral grafting of genetically modified cells. Applications to a rat model of Parkinson's disease.
Shimohama
S
S
Department of Neurology, Faculty of Medicine, Kyoto University, Japan.
Fisher
L J
LJ
Gage
F H
FH
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000503:physiopathology; D005347:Fibroblasts / Q000637:transplantation*; D005818:Genetic Engineering; D016627:Oxidopamine; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000235:genetics*; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects / Q000502:physiology; D014162:Transfection / Q000235:genetics*; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics*
D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase; D001058:Apomorphine